PT - JOURNAL ARTICLE AU - Li, Thomas Z. AU - Xu, Kaiwen AU - Chada, Neil C. AU - Chen, Heidi AU - Knight, Michael AU - Antic, Sanja AU - Sandler, Kim L. AU - Maldonado, Fabien AU - Landman, Bennett A. AU - Lasko, Thomas A. TI - Curating Retrospective Multimodal and Longitudinal Data for Community Cohorts at Risk for Lung Cancer AID - 10.1101/2023.11.03.23298020 DP - 2023 Jan 01 TA - medRxiv PG - 2023.11.03.23298020 4099 - http://medrxiv.org/content/early/2023/11/04/2023.11.03.23298020.short 4100 - http://medrxiv.org/content/early/2023/11/04/2023.11.03.23298020.full AB - Large community cohorts are useful for lung cancer research, allowing for the development and validation of predictive models. A robust methodology for (1) identifying lung cancer and pulmonary nodules from electronic health record (EHRs) as well as (2) associating longitudinal data with these conditions is needed to optimally curate cohorts at scale from clinical data. Both objectives present the challenge of labeling noisy multimodal data while minimizing assumptions about the data structure specific to any institution. In this study, we leveraged (1) SNOMED concepts to develop ICD-based decision rules for building a cohort that captured lung cancer and pulmonary nodules and (2) clinical knowledge to define time windows for collecting longitudinal imaging and clinical concepts. We curated three cohorts with clinical concepts and repeated imaging for subjects with pulmonary nodules from our Vanderbilt University Medical Center. Our approach achieved an estimated sensitivity 0.930 (95% CI: [0.879, 0.969]), specificity of 0.996 (95% CI: [0.989, 1.00]), positive predictive value of 0.979 (95% CI: [0.959, 1.000]), and negative predictive value of 0.987 (95% CI: [0.976, 0.994]). for distinguishing lung cancer from subjects with SPNs. This work represents a strategy for high-throughput curation of multi-modal longitudinal cohorts at risk for lung cancer from routinely collected EHRs.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was funded by the NIH through F30 fellowship 1F30CA275020, T32 training grants of 5T32GM007347-41 and 5T32GM007347-42, and R01CA253923. This work was funded in part by NSF CAREER 1452485 and NSF 2040462. This research is also supported by ViSE through T32EB021937-07 and the Vanderbilt Institute for Clinical and Translational Research through UL1TR002243-06.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB #140274 of Vanderbilt University Medical Center (VUMC) gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors